GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Effective Interest Rate on Debt %

4d pharma (4d pharma) Effective Interest Rate on Debt % : 22.16% (As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. 4d pharma's annualized positive value of Interest Expense for the quarter that ended in Dec. 2021 was $1.62 Mil. 4d pharma's average total debt for the quarter that ended in Dec. 2021 was $7.31 Mil. Therefore, 4d pharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2021 was 22.16%.


4d pharma Effective Interest Rate on Debt % Historical Data

The historical data trend for 4d pharma's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Effective Interest Rate on Debt % Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 343.75 7.41 99.85 17.01 11.09

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.13 16.34 16.29 0.14 22.16

Competitive Comparison of 4d pharma's Effective Interest Rate on Debt %

For the Biotechnology subindustry, 4d pharma's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4d pharma's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where 4d pharma's Effective Interest Rate on Debt % falls into.



4d pharma Effective Interest Rate on Debt % Calculation

4d pharma's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2020 )+Total Debt  (A: Dec. 2021 ))/ count )
=-1  *  -0.811/( (1.423+13.204)/ 2 )
=-1  *  -0.811/7.3135
=11.09 %

where

Total Debt  (A: Dec. 2020 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1.325 + 0.098
=1.423

Total Debt  (A: Dec. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.098 + 0.106
=13.204

4d pharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2021 )+Total Debt  (Q: Dec. 2021 ))/ count )
=-1  *  -1.62/( (1.417+13.204)/ 2 )
=-1  *  -1.62/7.3105
=22.16 %

where

Total Debt  (Q: Jun. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1.313 + 0.104
=1.417

Total Debt  (Q: Dec. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.098 + 0.106
=13.204

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2021) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


4d pharma  (OTCPK:LBPWQ) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


4d pharma Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of 4d pharma's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma (4d pharma) Business Description

Industry
Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (4d pharma) Headlines

From GuruFocus

4D pharma appoints John Doyle as Chief Financial Officer

By Business Wire Business Wire 01-03-2022

4D pharma Announces Passing of Chief Financial Officer John Beck

By Business Wire Business Wire 07-26-2021

4D pharma Announces $30 Million Credit Facility with Oxford Finance

By Business Wire Business Wire 07-29-2021

4D pharma to Present at the H.C. Wainwright Global Investment Conference

By Business Wire Business Wire 05-19-2022